Medical Journals

Histaminergic Receptors of Medial Septum and Conditioned Place Preference: D1 Dopamine Receptor Mechanism.

Authors:
  • Zarrindast Mohammad-Reza
  • Moghimi Maryam
  • Rostami Parvin
  • Rezayof Ameneh

From: Department of Pharmacology and Iranian National Center for Addiction Studies, School of Medicine, Tehran University of Medical Sciences, PO Box 13145-784, Tehran, Iran. zarinmr@ams.ac.ir

Brain research

  • Publish Date: Sep 2006
  • ISSN: 0006-8993
  • Volume: 1109
  • Issue: 1
  • Pages: 108-16
  • Medium: Print
  • Language: English
  • Citation (JAMA): Zarrindast Mohammad-Reza, Moghimi Maryam, Rostami Parvin, et al. Histaminergic Receptors of Medial Septum and Conditioned Place Preference: D1 Dopamine Receptor Mechanism.. Brain Res. Sep 2006;1109:108-16

Abstract

In the present study, the effects of intra-medial septum injections of histamine and/or the histamine H1 or H2 receptor antagonists on the acquisition of conditioned place preference (CPP) in male Wistar rats have been investigated. Our data showed that the conditioning treatments with intra-medial septum injection of different doses of histamine (0.5-15 microg/rat) induced a significant CPP for the drug-associated place. Using a 3-day schedule of conditioning, it was found that the histamine H1 receptor antagonist, pyrilamine (10 and 15 microg/rat, intra-medial septum) also induced a significant place preference. In addition, pyrilamine inhibited the histamine (7.5 microg/rat)-induced place preference. Intra-medial septum administration of the histamine H2 receptor antagonist, ranitidine (5-15 microg/rat) alone or in combination with histamine did not produce a significant place preference or place aversion. On the other hand, intra-medial septum administration of the dopamine D1 receptor antagonist, SCH 233390 (0.5, 0.75 and 1 microg/rat) inhibited the histamine (7.5 microg/rat) or pyrilamine (15 microg/rat)-induced place preference in a dose-dependent manner, but no effect was observed for the dopamine D2 receptor antagonist, sulpiride on the histamine or pyrilamine response. The administration of histamine (2.5-15 microg/rat) or pyrilamine (10 and 15 microg/rat) during acquisition increased locomotor activity of the animals on the testing days. The results suggest that histaminergic receptors of the medial septum may be involved in CPP and thus it is postulated that dopamine D1 receptors may play an important role in this effect.

Mesh Headings (Keywords): (R)-2,3,4,5-Tetrahydro-8-chloro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol, Analysis of Variance, Animals, Behavior, Animal, Conditioning (Psychology), Dopamine Antagonists, Dose-Response Relationship, Drug, Drug Interactions, Histamine, Histamine H1 Antagonists, Histamine H2 Antagonists, Male, Motor Activity, Pyrilamine, Ranitidine, Rats, Rats, Wistar, Reaction Time, Receptors, Dopamine, Receptors, Histamine, Septum of Brain, Sulpiride


Check for Full Text / PubMed Unique Identifier (PMID): 16828718


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.